Iterum Therapeutics plc
DUBLIN, L2 · Founded 2015 · CIK 0001659323 · Biotech · Defunct
Differentiated anti-infective drugs targeting multidrug-resistant pathogens
iterumtx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $127M
- 5 Form D · Jul 2020
- 75 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $23,790,001 | |
| Private capital raised | Form D · SEC | $45,867,493 | |
| Private capital raised | Form D · SEC | $51,588,000 | |
| Private capital raised | Form D · SEC | $2,844,627 | |
| Private capital raised | Form D · SEC | $2,832,102 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1730 | DEMERX, INC. | — | $290K |
| 1731 | Design Therapeutics, Inc. | — | $171M |
| 1732 | Halia Therapeutics, Inc. | — | $27M |
| 1733 | Iterum Therapeutics plc | — | $127M |
| 1734 | Jnana Therapeutics | — | $110M |
| 1735 | STRYKAGEN CORPORATION | — | — |
| 1736 | MB RESEARCH LABORATORIES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brenton AhrensDirector
- Louise BarrettExecutive Officer
- Mark ChinDirector
- Michael DunneExecutive Officer · Promoter
- Paul EdickDirector
- Corey FishmanDirector · Executive Officer · Promoter
- James HealyDirector
- Patrick HeronDirector
- Robert HopfnerDirector
- Ronald HuntDirector
- David KellyDirector
- Shahzad MalikDirector
- Judith MatthewsExecutive Officer · Promoter
- Tracy SaxtonDirector
- Jeff SchaffnitExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.